Stay updated on Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page.

Latest updates to the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content, indicating an access restriction rather than substantive changes to the trial information.SummaryDifference20%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor update to the page. There are no changes to study data, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check49 days agoChange DetectedNew study documents and metadata were added to the page, including the Informed Consent Form (2020-10-01, 1.77MB) and the Study Protocol and SAP, along with related terms and collaboration details. These additions broaden access to official materials and clarify collaborators and regulatory context.SummaryDifference61%

- Check57 days agoChange DetectedThe page's site revision label was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the prior v3.6.3, indicating an update to the page's revision history. This appears to be a metadata update rather than a change to the study details or content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page footer now lists Revision: v3.6.3, replacing Revision: v3.6.2, indicating a new version release of the page. It reflects an update to the page's documentation/versioning rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page.